Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Cash (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Change in Cash for 11 consecutive years, with $405.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 4682.88% year-over-year to $405.9 million, compared with a TTM value of $300.0 million through Dec 2025, up 194.77%, and an annual FY2025 reading of $300.0 million, up 194.77% over the prior year.
  • Change in Cash was $405.9 million for Q4 2025 at Wave Life Sciences, up from -$12.3 million in the prior quarter.
  • Across five years, Change in Cash topped out at $405.9 million in Q4 2025 and bottomed at -$88.9 million in Q1 2022.
  • Average Change in Cash over 5 years is $20.9 million, with a median of -$15.8 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 4682.88% in 2025, while the deepest fall reached 203.87% in 2025.
  • Year by year, Change in Cash stood at $26.7 million in 2021, then tumbled by 131.69% to -$8.5 million in 2022, then surged by 815.0% to $60.4 million in 2023, then crashed by 114.66% to -$8.9 million in 2024, then surged by 4682.88% to $405.9 million in 2025.
  • Business Quant data shows Change in Cash for WVE at $405.9 million in Q4 2025, -$12.3 million in Q3 2025, and -$34.6 million in Q2 2025.